Structures of active and latent PAI-1: A possible stabilizing role for chloride ions

被引:91
作者
Stout, TJ [1 ]
Graham, H [1 ]
Buckley, DI [1 ]
Matthews, DJ [1 ]
机构
[1] MetaXen, San Francisco, CA 94080 USA
关键词
D O I
10.1021/bi000290w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serpins exhibit a range of physiological roles and can contribute to certain disease states dependent on their various conformations. Understanding the mechanisms of the large-scale conformational reorganizations of serpins may lead to a better understanding of their roles in various cardiovascular diseases. We have studied the serpin, plasminogen activator inhibitor 1 (PAI-1), in both the active and the latent state and found that anionic halide ions may play a role in the active-to-latent structural transition. Crystallographic analysis of a stable mutant form of active PAI-1 identified an anion-binding site between the central beta-sheet and a small surface domain. A chloride ion was modeled in this site, and its identity was confirmed by soaking crystals in a bromide-containing solution and calculating a crystallographic difference map. The anion thus located forms a 4-fold ligated linchpin that tethers the surface domain to the central beta-sheet into which the reactive center loop must insert during the active-to-latent transition. Timecourse experiments measuring active PAI-1 stability in the presence of various halide ions showed a clear trend for stabilization of the active form with F- > Cl- > Br- >> I-. We propose that the "stickiness" of this pin (i.e., the electronegativity of the anion) contributes to the energetics of the active-to-latent transition in the PAI-1 serpin.
引用
收藏
页码:8460 / 8469
页数:10
相关论文
共 47 条
[1]   PURIFICATION AND CHARACTERIZATION OF NATURAL AND RECOMBINANT HUMAN-PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) [J].
ALESSI, MC ;
DECLERCK, PJ ;
DEMOL, M ;
NELLES, L ;
COLLEN, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (03) :531-540
[2]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - REACTIVE CENTER AND AMINO-TERMINAL HETEROGENEITY DETERMINED BY PROTEIN AND CDNA SEQUENCING [J].
ANDREASEN, PA ;
RICCIO, A ;
WELINDER, KG ;
DOUGLAS, R ;
SARTORIO, R ;
NIELSEN, LS ;
OPPENHEIMER, C ;
BLASI, F ;
DANO, K .
FEBS LETTERS, 1986, 209 (02) :213-218
[3]   How Hofmeister ion interactions affect protein stability [J].
Baldwin, RL .
BIOPHYSICAL JOURNAL, 1996, 71 (04) :2056-2063
[4]   MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY [J].
BERKENPAS, MB ;
LAWRENCE, DA ;
GINSBURG, D .
EMBO JOURNAL, 1995, 14 (13) :2969-2977
[5]   Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis [J].
Björquist, P ;
Ehnebom, J ;
Inghardt, T ;
Hansson, L ;
Lindberg, M ;
Linschoten, M ;
Strömqvist, M ;
Deinum, J .
BIOCHEMISTRY, 1998, 37 (05) :1227-1234
[6]  
BRUNGER AT, 1996, X PLOR
[7]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[8]  
DECLERCK PJ, 1992, J BIOL CHEM, V267, P11693
[9]  
EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606
[10]   Divining the serpin inhibition mechanism: A suicide substrate 'springe'? [J].
Engh, RA ;
Huber, R ;
Bode, W ;
Schulze, AJ .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (12) :503-510